Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells

Table 6

Liver fibrosis staging of three groups after treatment (according to the criteria of Scheuer’s criteria).

n	Control group	Cirrhotic group	FZHY treatment group
S0	5 (100%)	0 (0%)	0 (0%)
S1	0 (0%)	0 (0%)	1 (10%)
S2	0 (0%)	1 (10%)	5 (50%)
S3	0 (0%)	5 (50%)	3 (30%)
S4	0 (0%)	4 (40%)	1 (10%)
Total	5	10	10

versus S4 of cirrhotic group; S, stage of liver fibrosis (S0–S4).